BACKGROUND Children with diffuse midline glioma (DMG) face dismal prognoses. PNOC DMG-ACT (DMG-Adaptive Combination Trial, PNOC022) is an open-label, international trial investigating the efficacy of combination therapies for patients with DMG.
C. Kline +38 more
semanticscholar +1 more source
Multiblock analysis of omics and imaging data with variable selection
Congrès sous l’égide de la Société Française de Génie Biologique et Médical (SFGBM)National audienceSparse generalized canonical correlation analysis (SGCCA) has been proposed to combine RGCCA with an ℓ 1-penalty in a unified framework.
Frouin, Vincent +4 more
core
Epigenetic mechanisms and therapeutic advances in diffuse midline glioma (Review). [PDF]
Wu W, Chen W, Ma W, Wang Y.
europepmc +1 more source
A deep learning-based automatic segmentation model for diffuse midline glioma with H3K27M alteration. [PDF]
Deng Y, Chen T, Zhang Y, Huang B.
europepmc +1 more source
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. [PDF]
Banerjee, Anu +44 more
core
Adult-Onset Diffuse Midline Glioma, H3K27-Altered: A Genomics-Guided, Individualized, Multimodal Treatment Approach. [PDF]
Çelebi A +8 more
europepmc +1 more source
Malignant Tumor (2) Molecular Genetics in the Pathological Diagnostics of Cancer [PDF]
増井 憲太
core +1 more source
Diffuse midline glioma treated with epigenetic agent-based immunotherapy
Linkai Jing +9 more
doaj +1 more source
Photodynamic therapy for recurrent spinal diffuse midline glioma with a modest extension of overall survival: illustrative case. [PDF]
Fukumura M +9 more
europepmc +1 more source

